Overview

Studies of Prognostic Factors in Castration Resistant PROState Cancer Treated With Abiraterone

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Prospective Multi-centre Studies of Prognostic Factors in Castration resistant PROState Cancer Treated With Abiraterone (PROSABI)
Phase:
N/A
Details
Lead Sponsor:
Centro Nacional de Investigaciones Oncologicas CARLOS III
Treatments:
Abiraterone Acetate